Screener
Bristol-Myers Squibb BMY Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Bristol-Myers Squibb’s reported figures.
Based on trailing twelve months.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
FAQ
- What is Bristol-Myers Squibb's free cash flow margin?
- Bristol-Myers Squibb (BMY) reported free cash flow margin of 23.3% in Q2 2026.
- How has Bristol-Myers Squibb's free cash flow margin changed year-over-year?
- Bristol-Myers Squibb's free cash flow margin decreased by 23.9% year-over-year, from 30.6% to 23.3%.
- What is the long-term trend for Bristol-Myers Squibb's free cash flow margin?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's free cash flow margin has grown at a -3.2% compound annual growth rate (CAGR), from 31.3% to 26.7%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Bristol-Myers Squibb's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude